EMPACT-MI trial; empagliflozin; SGTL2i; MI; heart failure

Name: No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Uploaded: 2024-04-06T04:00:00+00:00
Duration: 3 min 17 s
Description: ACC.24 - Javed Butler shares the findings of the EMPACT-MI trial, in which empagliflozin had no effect on the primary endpoint in patients with acute MI bu